🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 98985W102
- Market Cap
- Mid Cap · $753 Million
- IPO
- 4/27/2017 · $13.00/share
Business: Zymeworks, Inc. is a clinical-stage biopharmaceutical company dedicated to the discovery, development and commercialization of next-generation multifunctional biotherapeutics, initially focused on the treatment of cancer. Zymeworks’ suite of complementary therapeutic platforms and its fully-integrated drug development engine provide the flexibility and compatibility to precisely engineer and develop highly-differentiated product candidates.
Company Contact
- CEO
- Kenneth Galbraith
- CFO
- Chris Astle
- Headquarters
- 540-1385 West 8th Avenue, Vancouver, British Columbia V6H 3V9 Canada
- Phone
- 604-678-1388
- Investor Relations
- David Matousek · 604-678-1388 · ir@zymeworks.com